McCurdy S, Keedy K, Lawrence L, Nenninger A, et al. Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory
Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP):
Microbiology Results from the Delafloxacin Phase 3 CABP Trial. Antimicrob Agents Chemother 2020;64.
PMID: 31844013